New drug tested to protect kidneys during cancer treatment
NCT ID NCT04745910
Summary
This study is testing if a drug called pegloticase can quickly lower dangerously high uric acid levels in cancer patients. High uric acid is a side effect of some cancer treatments and can damage the kidneys. The goal is to see if one or two doses of pegloticase can protect kidney function better than current treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.